{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:07:03Z","timestamp":1791094023217,"version":"4.1.0"},"reference-count":20,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T00:00:00Z","timestamp":1219881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Pediatric lymphoblastic lymphoma (LL) has utilized treatment strategies similar to childhood acute lymphoblastic leukaemia (ALL) with prolonged maintenance chemotherapy. We report the results of a pilot study to estimate the feasibility, toxicity and efficacy of a 12\u2010month aggressive multi\u2010agent chemotherapy regimen in children and adolescents with advanced LL. Between July 1994 and June 1997, 85 eligible children and adolescents with advanced LL (Stage III\/IV) were enrolled on this pilot study. Patients achieving a complete response following induction and consolidation received six cycles of maintenance chemotherapy for a total duration of 12\u2003months. Grade III\/IV toxicities included: hematological (80%), infections (20%), stomatitis and elevated transaminases, (29%). There were a total of 19 events, 13 relapses, two secondary acute myeloid leukaemia and four toxic deaths (5%). The 5\u2010year event\u2010free survival (EFS) and overall survival (OS) was 78\u2003\u00b1\u20034\u00b75% and 85\u2003\u00b1\u20033\u00b79%, respectively. Relapsed patients had a 5\u2010year OS of only 33\u2003\u00b1\u200314%. Multivariate analysis failed to demonstrate age, gender, lactate dehydrogenase level, presence of marrow and\/or central nervous system disease to have independent prognostic value. These results suggest that this experimental approach is safe and results in similar outcomes as more prolonged childhood ALL regimens.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07320.x","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T09:48:30Z","timestamp":1219916910000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Shortened intensified multi\u2010agent chemotherapy and non\u2010cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children\u2019s Oncology Group"],"prefix":"10.1111","volume":"143","author":[{"given":"Minnie","family":"Abromowitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sposto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S.","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198303103081003"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.6.1024"},{"key":"e_1_2_6_4_1","first-page":"867a","article-title":"Childhood T\u2010cell lymphoblastic lymphoma (TLL) results of the SFOP LMT96 strategy","volume":"46","author":"Bergeron C.","year":"2006","journal-title":"Pediatric Blood & Cancer"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.2707"},{"key":"e_1_2_6_6_1","first-page":"840a","article-title":"Clinical and biological significance of loss of heterozygosity at chromosome 6q in children and adolescents with T\u2010cell lymphoblastic lymphoma","volume":"46","author":"Burkhardt B.","year":"2006","journal-title":"Pediatric Blood & Cancer"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20342"},{"key":"e_1_2_6_8_1","article-title":"A novel approach for minimal residual disease detection in childhood T\u2010cell lymphoblastic lymphoma (T\u2010LL): a Children\u2019s Oncology Group Report","author":"Coustan\u2010Smith E.","year":"2007","journal-title":"American Society of Hematology"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood.V66.5.1110.1110","article-title":"A novel treatment of childhood lymphoblastic non\u2010Hodgkin\u2019s lymphoma: early and intermittent use of teniposide plus cytarabine","volume":"66","author":"Dahl G.V.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb06423.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(03)00195-1"},{"key":"e_1_2_6_12_1","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalbfleisch J.D.","year":"1980"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11615"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1984.201"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950200204"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20550"},{"key":"e_1_2_6_17_1","first-page":"416","article-title":"Intensive ALL\u2010type therapy without local radiotherapy provides a 90% event\u2010free survival for children with T\u2010cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter A.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.1986.4.5.744","article-title":"Improved disease\u2010free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen\u2013a new intensive therapy protocol: a report from the Childrens Cancer Study Group","volume":"4","author":"Steinherz P.G.","year":"1986","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.6.1368"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.02.011"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.9.537"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07320.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07320.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:16:41Z","timestamp":1695921401000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07320.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,24]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07320.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07320.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,24]]},"assertion":[{"value":"2008-09-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}